Rosalind Advisors »

Pepgen shares owned by Rosalind Advisors

Quarter-by-quarter ownership of Pepgen (PEPG) shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in Pepgen

Tip: Access up to 7 years of quarterly data

All positions including Pepgen held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pepgen by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $630k 350k 1.80

More positions owned by Rosalind Advisors

Delcath Systems Com New (DCTH)
Fennec Pharmaceuticals (FENC)
Xeris Pharmaceuticals (XERS)
Savara (SVRA)
Verastem Com New (VSTM)
X4 Pharmaceuticals Com New (XFOR)
Eyepoint Pharmaceuticals Com New (EYPT)
Cybin Com New (HELP)
Vor Biopharma Com New (VOR)
Vaxcyte (PCVX)
Mediwound Shs New (MDWD)
Celldex Therapeutics Com New (CLDX)
BioCryst Pharmaceuticals (BCRX)
Profound Medical Corp Com New (PROF)
Talphera Com New (TLPH)

View all positions for Rosalind Advisors

Top funds holding Pepgen

RA Capital Management
Commodore Capital
Viking Global Investors
Laurion Capital Management
ADAR1 Capital Management
Vivo Capital
Vanguard Capital Management
Millennium Management
Renaissance Technologies
BlackRock
Morgan Stanley
Marshall Wace
GSA Capital Partners
Citadel Advisors
AWM Investment Company

View all funds holding Pepgen